Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus

Verena Battisti, Julia Moesslacher, Rana Abdelnabi, Pieter Leyssen, Ana Lucia Rosales Rosas, Lana Langendries, Mohammed Aufy, Christian Studenik, Jadel M Kratz, Judith M Rollinger, Gerhard Puerstinger, Johan Neyts, Leen Delang, Ernst Urban, Thierry Langer

Publications: Contribution to journalArticlePeer Reviewed

Abstract

The worldwide re-emerge of the Chikungunya virus (CHIKV), the high morbidity associated with it, and the lack of an available vaccine or antiviral treatment make the development of a potent CHIKV-inhibitor highly desirable. Therefore, an extensive lead optimization was performed based on the previously reported CHVB compound 1b and the reported synthesis route was optimized - improving the overall yield in remarkably shorter synthesis and work-up time. Hundred analogues were designed, synthesized, and investigated for their antiviral activity, physiochemistry, and toxicological profile. An extensive structure-activity relationship study (SAR) was performed, which focused mainly on the combination of scaffold changes and revealed the key chemical features for potent anti-CHIKV inhibition. Further, a thorough ADMET investigation of the compounds was carried out: the compounds were screened for their aqueous solubility, lipophilicity, their toxicity in CaCo-2 cells, and possible hERG channel interactions. Additionally, 55 analogues were assessed for their metabolic stability in human liver microsomes (HLMs), leading to a structure-metabolism relationship study (SMR). The compounds showed an excellent safety profile, favourable physicochemical characteristics, and the required metabolic stability. A cross-resistance study confirmed the viral capping machinery (nsP1) to be the viral target of these compounds. This study identified 31b and 34 as potent, safe, and stable lead compounds for further development as selective CHIKV inhibitors. Finally, the collected insight led to a successful scaffold hop (64b) for future antiviral research studies.

Original languageEnglish
Article number116010
JournalEuropean Journal of Medicinal Chemistry
Volume264
Early online date2023
DOIs
Publication statusPublished - 15 Jan 2024

Austrian Fields of Science 2012

  • 301207 Pharmaceutical chemistry

Fingerprint

Dive into the research topics of 'Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus'. Together they form a unique fingerprint.

Cite this